Editorial: Monitoring methotrexate polyglutamates in Crohn's disease-Authors' reply
- PMID: 38085943
- DOI: 10.1111/apt.17795
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease-Authors' reply
Comment on
-
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease.Aliment Pharmacol Ther. 2024 Jan;59(1):118-119. doi: 10.1111/apt.17743. Aliment Pharmacol Ther. 2024. PMID: 38085937 No abstract available.
References
REFERENCES
-
- Barclay ML, Stamp LK. Editorial: monitoring methotrexate polyglutamates in Crohn's disease. Aliment Pharmacol Ther. 2024;59:118-119.
-
- van de Meeberg MM, Fidder HH, Oldenburg B, Sundaresan J, Struys EA, Montazeri NSM, et al. On behalf of the Dutch initiative on Crohn and colitis (ICC).Therapeutic drug monitoring of methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther. 2023;58:1151-1162.
-
- van de Meeberg MM, Hebing RCF, Nurmohamed MT, Fidder HH, Heymans MW, Bouma G, et al. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis. Br J Clin Pharmacol. 2023;89:61-79.
-
- Hebing RCF, Bartelink IH, Gosselt HR, Heil SG, de Rotte MCFJ, de Jong PHP, et al. Methotrexate polyglutamates exposure-response modeling in a large cohort of rheumatoid arthritis patients starting methotrexate. Clin Pharmacol Ther. 2023;114:893-903.
-
- Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, et al. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum. 2004;50:2766-2774.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical